Enhanc3D in a $7.7M series A extension with Business Growth Fund, Parkwalk Advisors and Bioqube Ventures
18 September 2025
18 September 2025
Total investments received (USD): 18.98M
Round value (USD): 7.7M
Company: Enhanc3D
Related deals
Brainomix in a £4.8 million Series C extension co-led by Parkwalk and Hostplus, joined by Modi Ventures.
Investments
13 February 2026
Centauri Therapeutics secured a £6 million series A extension investment from the AMR Action Fund,
Investments
08 February 2026
Tozaro in a £6M financing round with equity contributed by Mercia Ventures and Midlands Engine Investment Fund in the UK
Investments
06 February 2026
NuVision raises £4.8M in an equity round led by Mercia Ventures, University of Nottingham and Pioneer in the UK
Investments
06 January 2026
Solve Chemistry raises a £4m seed round led by XTX Ventures, with Endgame Capital, SuperSeed, Creator Fund, Inovia Capital, Redbus Ventures
Investments
04 January 2026
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain